Skip to main content
IMULDOSA 45 mg/.5mL injection by Accord BioPharma Inc.
IMULDOSA, 45 mg/.5mL, injection Drug class: Interleukin-12 Antagonist; Interleukin-23 Antagonist. Available on prescription only. Listed by Accord BioPharma Inc..
Prescription only

IMULDOSA

ustekinumab-srlf

Listed by Accord BioPharma Inc.

Strength
45 mg/.5mL
Form
Injection
Route
Subcutaneous
Class
Interleukin-12 Antagonist; Interleukin-23 Ant…

What it contains

  • Ustekinumab-srlf 45 mg/.5mL

FDA record

Dosage form Injection
Route Subcutaneous
Drug class Interleukin-12 Antagonist; Interleukin-23 Antagonist
Approval route BLA — biologic licence
NDC code 69448-017
FDA application BLA761364
RxNorm concept 2717067
Package sizes listed 1
Marketed since October 2024

Other products containing Ustekinumab Srlf

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

IMULDOSA

ustekinumab-srlf

Strength
90 mg/mL
Form
Injection
Class
Interleukin-12 Antagonist; Interleukin-…
Rx only

Accord BioPharma Inc.

Not stocked by us — reference only

IMULDOSA

ustekinumab-srlf

Strength
130 mg/26mL
Form
Injection
Class
Interleukin-12 Antagonist; Interleukin-…
Rx only

Accord BioPharma Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.